Position in CGON
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$31,688
+$10,437 QoQ
Shares Held
446
+42.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#191
of 226 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Covestor Ltd holds $4,614,813 across 168 Biotechnology names. CGON ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
6,774 | $902,703 | |
| 2 | PRTA |
Prothena Corp Public Ltd Co
|
25,190 | $246,610 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,528 | $187,302 | |
| 4 | INCY |
Incyte Corp
|
1,629 | $184,663 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
493 | $183,233 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
368 | $182,796 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
936 | $175,294 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
2,093 | $155,886 |
All Filings in CGON
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,688 | 446 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $21,251 | 314 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $14,490 | 349 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $18,730 | 465 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $12,194 | 469 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $97 | 4 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $114 | 4 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $150 | 4 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $126 | 4 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||